WASHINGTON, D.C. — Patients For Affordable Drugs Executive Director, Ben Wakana, issued the following statement regarding the Trump Administration’s plans to introduce tariffs on key drug ingredients.

“For an administration that wants to lower drug prices, this would do the exact opposite. We are eager to read the comprehensive set of recommendations the administration promised to release in the next few weeks, but the tariffs announced yesterday would be a step in the wrong direction. It’s a tax that would raise prices on prescription drugs.”